CALLIE TRENT: Open Payments
NPI 1982274254 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 64 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $301 |
| Ardelyx, Inc. | 8 | $198 |
| ABBVIE INC. | 11 | $189 |
| Phathom Pharmaceuticals, Inc. | 10 | $101 |
| EVOKE PHARMA, INC. | 5 | $87 |
| GENZYME CORPORATION | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| Teleflex LLC | 2 | $40 |
| 180 Medical, Inc. | 1 | $26 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, RINVOQ, GIMOTI, CREON, DUPIXENT, Wegovy.
Industry payments across KY — which companies pay providers there.
